822
BACKGROUND: Etanercept is a tumor necrosis factor (TNF) inhibitor that has been licensed in the United States for the treatment of adult and juvenile rheumatoid arthritis as well as psoriatic arthritis.
 adult and juvenile rheumatoid arthritis as well as psoriatic arthritis: Subject; adult: Subject.Age; juvenile: Subject.Age; Etanercept: Treatment; a tumor necrosis factor (TNF) inhibitor: Treatment; Etanercept: Treatment.Drug; adult and juvenile rheumatoid arthritis: Treatment.Disorder; psoriatic arthritis: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 adult and juvenile rheumatoid arthritis as well as psoriatic arthritis: Subject; adult: Subject.Age; juvenile: Subject.Age; Etanercept: Treatment; a tumor necrosis factor (TNF) inhibitor: Treatment; Etanercept: Treatment.Drug; adult and juvenile rheumatoid arthritis: Treatment.Disorder; psoriatic arthritis: Treatment.Disorder